Literature DB >> 15857786

Whole plasmid mutagenic PCR for directed protein evolution.

Ichiro Matsumura1, Lori A Rowe.   

Abstract

Protein function can be engineered through iterated cycles of random mutagenesis and screening (directed evolution). Optimization of protein expression is essential for the development of sensitive and precise high throughput assays. Here we optimize the performance of a plasmid-borne Escherichia coli lacZ gene in two rounds of directed evolution. First, its promoter was "randomized" by whole plasmid polymerase chain reaction (PCR) and intra-molecular self-ligation. A genetically stable constitutive expression vector was isolated in an in vivo genetic selection. Second, the entire plasmid was randomly mutated in a slightly mutagenic long polymerase chain reaction. The PCR products were digested with a restriction enzyme, self-ligated by T4 DNA ligase and transformed into E. coli. The resulting library of beta-galactosidase (beta-gal) mutants consisted mostly ( approximately 80%) of hypomorphs, suggesting that the mutation rate was appropriate for directed evolution applications. We isolated and characterized 14 variants with increased activity in reactions with 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside (X-gal). The purified protein derived from one clone exhibited a 100-fold improvement in k(cat) over its parent in reactions with para-nitrophenyl-beta-d-galactopyranoside (pNP-gal). This latter result clearly demonstrates the utility of whole plasmid mutagenic PCR for directed protein evolution.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857786     DOI: 10.1016/j.bioeng.2004.10.004

Source DB:  PubMed          Journal:  Biomol Eng        ISSN: 1389-0344


  8 in total

1.  Site-saturation mutagenesis is more efficient than DNA shuffling for the directed evolution of beta-fucosidase from beta-galactosidase.

Authors:  Monal R Parikh; Ichiro Matsumura
Journal:  J Mol Biol       Date:  2005-09-23       Impact factor: 5.469

2.  Defining structural domains of an intrinsically disordered protein: Sic1, the cyclin-dependent kinase inhibitor of Saccharomyces cerevisiae.

Authors:  Stefania Brocca; Lorenzo Testa; Maria Samalikova; Rita Grandori; Marina Lotti
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

3.  Replacing Mn(2+) with Co(2+) in human arginase i enhances cytotoxicity toward l-arginine auxotrophic cancer cell lines.

Authors:  Everett M Stone; Evan S Glazer; Lynne Chantranupong; Paul Cherukuri; Robert M Breece; David L Tierney; Steven A Curley; Brent L Iverson; George Georgiou
Journal:  ACS Chem Biol       Date:  2010-03-19       Impact factor: 5.100

4.  Order propensity of an intrinsically disordered protein, the cyclin-dependent-kinase inhibitor Sic1.

Authors:  Stefania Brocca; Mária Samalíková; Vladimir N Uversky; Marina Lotti; Marco Vanoni; Lilia Alberghina; Rita Grandori
Journal:  Proteins       Date:  2009-08-15

5.  Thermostable DNA ligase-mediated PCR production of circular plasmid (PPCP) and its application in directed evolution via in situ error-prone PCR.

Authors:  Yilin Le; Huayou Chen; Robert Zagursky; J H David Wu; Weilan Shao
Journal:  DNA Res       Date:  2013-04-30       Impact factor: 4.458

6.  OmniChange: the sequence independent method for simultaneous site-saturation of five codons.

Authors:  Alexander Dennig; Amol V Shivange; Jan Marienhagen; Ulrich Schwaneberg
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

7.  Reciprocal influence of protein domains in the cold-adapted acyl aminoacyl peptidase from Sporosarcina psychrophila.

Authors:  Federica Parravicini; Antonino Natalello; Elena Papaleo; Luca De Gioia; Silvia Maria Doglia; Marina Lotti; Stefania Brocca
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

Review 8.  Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently.

Authors:  Andrew Currin; Neil Swainston; Philip J Day; Douglas B Kell
Journal:  Chem Soc Rev       Date:  2015-03-07       Impact factor: 54.564

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.